This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Nielsen AO, Pedersen L, Sode BF, Dahl M. β-Blocker therapy and risk of chronic obstructive pulmonary disease – a Danish nationwide study of 1.3 million individuals. EClinicalMedicine. 2019;7: 21–26.NielsenAOPedersenLSodeBFDahlMβ-Blocker therapy and risk of chronic obstructive pulmonary disease – a Danish nationwide study of 1.3 million individualsEClinicalMedicine20197212610.1016/j.eclinm.2019.01.004653752831193622Search in Google Scholar
Corlățeanu A, Odajiu I, Botnaru V, Cemirtan S. From smoking to COPD – current approaches. Pneumologia. 2016;65(1): 20–23.CorlățeanuAOdajiuIBotnaruVCemirtanSFrom smoking to COPD – current approachesPneumologia20166512023Search in Google Scholar
Schnell K, Weiss CO, Lee T, Krishnan J, Leff B, Wolff JL, et al. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: A cross-sectional study using data from NHANES 1999–2008. BMC Pulmonary Medicine. 2012;12: 26.SchnellKWeissCOLeeTKrishnanJLeffBWolffJLThe prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: A cross-sectional study using data from NHANES 1999–2008BMC Pulmonary Medicine2012122610.1186/1471-2466-12-26346143322695054Search in Google Scholar
Laforest L, Roche N, Devouassoux G, Belhassen M, Chouaid C, Ginoux M, et al. Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study. Respiratory Medicine. 2016;117: 33–39.LaforestLRocheNDevouassouxGBelhassenMChouaidCGinouxMFrequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort studyRespiratory Medicine2016117333910.1016/j.rmed.2016.05.01927492511Search in Google Scholar
Morgan AD, Zakeri R, Quint JK. Defining the relationship between COPD and CVD: What are the implications for clinical practice? Therapeutic Advances in Respiratory Disease. 2018; 12: 1–16.MorganADZakeriRQuintJKDefining the relationship between COPD and CVD: What are the implications for clinical practice?Therapeutic Advances in Respiratory Disease20181211610.1177/1753465817750524593715729355081Search in Google Scholar
Rabe KF, Hurst JR, Suissa S. Cardiovascular disease and COPD: Dangerous liaisons? European Respiratory Revire. 2018;27: 180057.RabeKFHurstJRSuissaSCardiovascular disease and COPD: Dangerous liaisons?European Respiratory Revire20182718005710.1183/16000617.0057-201830282634Search in Google Scholar
Krynytska I, Marushchak M, Zaets T, Savchenko I, Habor H. Investigation of bone mineralization in patients with coronary heart disease complicated by chronic heart failure, stage II-A. GMN. 2017;267: 43–48.KrynytskaIMarushchakMZaetsTSavchenkoIHaborHInvestigation of bone mineralization in patients with coronary heart disease complicated by chronic heart failure, stage II-AGMN20172674348Search in Google Scholar
Trinkmann F, Saur J, Borggrefe M, Akin I. Cardiovascular Comorbidities in Chronic Obstructive Pulmonary Disease (COPD)—current considerations for clinical practice. Journal of Clinical Medicine. 2019;8: 69.TrinkmannFSaurJBorggrefeMAkinICardiovascular Comorbidities in Chronic Obstructive Pulmonary Disease (COPD)—current considerations for clinical practiceJournal of Clinical Medicine201986910.3390/jcm8010069635226130634565Search in Google Scholar
Marushchak M, Krynytska I, Mikolenko A, Andreychyn Y, Bodnar Y. Chronic heart failure causes osteopathy or is osteopathy a factor in development of chronic heart failure? AJPCR. 2018;11(1): 111–115.MarushchakMKrynytskaIMikolenkoAAndreychynYBodnarYChronic heart failure causes osteopathy or is osteopathy a factor in development of chronic heart failure?AJPCR2018111111115Search in Google Scholar
Rutten FH, Cramer MJ, Grobbee DE, Sachs AP, Kirkels JH, Lammers JW, et al. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. European Heart Journal. 2005;26: 1887–1894.RuttenFHCramerMJGrobbeeDESachsAPKirkelsJHLammersJWUnrecognized heart failure in elderly patients with stable chronic obstructive pulmonary diseaseEuropean Heart Journal2005261887189410.1093/eurheartj/ehi29115860516Search in Google Scholar
Macchia A, Rodriguez Moncalvo JJ, Kleinert M, Comignani PD, Gimeno G, Arakaki D. Unrecognised ventricular dysfunction in COPD. The European Respiratory Journal. 2012;39: 51–58.MacchiaARodriguez MoncalvoJJKleinertMComignaniPDGimenoGArakakiDUnrecognised ventricular dysfunction in COPDThe European Respiratory Journal201239515810.1183/09031936.0004441121700606Search in Google Scholar
Wheaton AG, Ford ES, Cunningham TJ, Croft JB. Chronic obstructive pulmonary disease, hospital visits, and comorbidities: National Survey of Residential Care Facilities, 2010. Journal of Aging and Health. 2015;27: 480–499.WheatonAGFordESCunninghamTJCroftJBChronic obstructive pulmonary disease, hospital visits, and comorbidities: National Survey of Residential Care Facilities, 2010Journal of Aging and Health20152748049910.1177/0898264314552419444120425288588Search in Google Scholar
Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478: 103–109.EhretGBMunroePBRiceKMBochudMJohnsonADChasmanDIGenetic variants in novel pathways influence blood pressure and cardiovascular disease riskNature201147810310910.1038/nature10405334092621909115Search in Google Scholar
Ayada С, Toru Ü, Genç O. Evaluation of whether the ACE gene I/D polymorphism constitutes a risk factor for chronic obstructive pulmonary disease in the Turkish population. Genetics and Molecular Research. 2014;13(4): 10427–10433.AyadaСToruÜGençOEvaluation of whether the ACE gene I/D polymorphism constitutes a risk factor for chronic obstructive pulmonary disease in the Turkish populationGenetics and Molecular Research2014134104271043310.4238/2014.December.12.4Search in Google Scholar
Simsek S, Tekes S, Oral D. The insertion/deletion polymorphism in the ACE gene and chronic obstructive pulmonary disease. Genetics and Molecular Research. 2013;12(2): 1392–1398.SimsekSTekesSOralDThe insertion/deletion polymorphism in the ACE gene and chronic obstructive pulmonary diseaseGenetics and Molecular Research20131221392139810.4238/2013.April.25.10Search in Google Scholar
Shanmuganathan R, Kumaresan R, Giri P. Prevalence of angiotensin converting enzyme (ACE) gene insertion/deletion polymorphism in South Indian population with hypertension and chronic kidney disease. Journal of Postgraduate Medicine. 2015;61(4): 230–234.ShanmuganathanRKumaresanRGiriPPrevalence of angiotensin converting enzyme (ACE) gene insertion/deletion polymorphism in South Indian population with hypertension and chronic kidney diseaseJournal of Postgraduate Medicine201561423023410.4103/0022-3859.166510Search in Google Scholar
Yun CM, Sang XY. Role of proteinase-activated receptor-1 gene polymorphisms in susceptibility to chronic obstructive pulmonary disease. Genetics and Molecular Research. 2015;14(4): 13215–13220.YunCMSangXYRole of proteinase-activated receptor-1 gene polymorphisms in susceptibility to chronic obstructive pulmonary diseaseGenetics and Molecular Research2015144132151322010.4238/2015.October.26.18Search in Google Scholar
Essa ES, Wahsh RA. Association between Plasminogen activator inhibitor-1-675 4G/5G insertion/deletion polymorphism and chronic obstructive pulmonary disease. COPD. 2016;13(6): 756–759.EssaESWahshRAAssociation between Plasminogen activator inhibitor-1-675 4G/5G insertion/deletion polymorphism and chronic obstructive pulmonary diseaseCOPD201613675675910.3109/15412555.2016.1168392Search in Google Scholar
Wang W, Li P, Chen Y, Yang J. Association between β2-adrenergic receptor-16Arg/Gly gene polymorphism and chronic obstructive pulmonary disease risk: Systematic review and meta-analysis. Iran Journal of Public Health. 2014;43(7): 877–888.WangWLiPChenYYangJAssociation between β2-adrenergic receptor-16Arg/Gly gene polymorphism and chronic obstructive pulmonary disease risk: Systematic review and meta-analysisIran Journal of Public Health2014437877888Search in Google Scholar
Kang SW, Kim SK, Chung JH, Jung HJ, Kim KI, Kim J, et al. Genetic polymorphism of angiotensin-converting enzyme and chronic obstructive pulmonary disease risk: An updated meta-analysis. BioMed Research International. 2016;2016: 7636123.KangSWKimSKChungJHJungHJKimKIKimJGenetic polymorphism of angiotensin-converting enzyme and chronic obstructive pulmonary disease risk: An updated meta-analysisBioMed Research International20162016763612310.1155/2016/7636123Search in Google Scholar
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. European Heart Journal. 2018;39(33): 3021–3104.WilliamsBManciaGSpieringWAgabiti RoseiEAziziMBurnierM2018 ESC/ESH guidelines for the management of arterial hypertensionEuropean Heart Journal201839333021310410.1201/9780429199189-75Search in Google Scholar
Lechin M, Quiñones MA, Omran A, Hill R, Yu QT, Rakowski H, et al. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation. 1995;92: 1808–1812.LechinMQuiñonesMAOmranAHillRYuQTRakowskiHAngiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathyCirculation1995921808181210.1161/01.CIR.92.7.1808Search in Google Scholar
Turner AJ, Hooper NM. The angiotensin converting enzyme gene family: Genomics and pharmacology. Trends in Pharmacological Science. 2002;23: 177–183.TurnerAJHooperNMThe angiotensin converting enzyme gene family: Genomics and pharmacologyTrends in Pharmacological Science20022317718310.1016/S0165-6147(00)01994-5Search in Google Scholar
Pang S, Chubb AJ, Schwager SL, Ehlers MR, Sturrock ED, Hooper NM, et al. Roles of the juxtamembrane and extracellular domains of the angiotensin-converting enzyme in ectodomain shedding. The Biochemical Journal. 2001;358: 185–192.PangSChubbAJSchwagerSLEhlersMRSturrockEDHooperNMRoles of the juxtamembrane and extracellular domains of the angiotensin-converting enzyme in ectodomain sheddingThe Biochemical Journal200135818519210.1042/bj3580185Search in Google Scholar
Parkin ET, Turner AJ, Hooper NM. Secretase-mediated cell surface shedding of the angiotensin converting enzyme. Protein & Peptide Letters. 2004;11: 423–432.ParkinETTurnerAJHooperNMSecretase-mediated cell surface shedding of the angiotensin converting enzymeProtein & Peptide Letters20041142343210.2174/092986604340654415544563Search in Google Scholar
Close P, Kehoe G, Miners S, Love S. Angiotensin in Alzheimer’s disease – friend or foe? Trends in Neuroscience. 2009;32: 619–628.ClosePKehoeGMinersSLoveSAngiotensin in Alzheimer’s disease – friend or foe?Trends in Neuroscience20093261962810.1016/j.tins.2009.07.00619796831Search in Google Scholar
Kon SS, Jolley CJ, Shrikrishna D. ACE and response to pulmonary rehabilitation in COPD: Two observational studies. BMJ Open Respiratory Research. 2017;4: 000165.KonSSJolleyCJShrikrishnaDACE and response to pulmonary rehabilitation in COPD: Two observational studiesBMJ Open Respiratory Research2017400016510.1136/bmjresp-2016-000165535325228321311Search in Google Scholar
Pabst S, Theis B, Gillissen A. Angiotensin-converting enzyme I/D polymorphism in chronic obstructive pulmonary disease. European Journal of Medical Research. 2009;14(4): 177–181.PabstSTheisBGillissenAAngiotensin-converting enzyme I/D polymorphism in chronic obstructive pulmonary diseaseEuropean Journal of Medical Research200914417718110.1186/2047-783X-14-S4-177352136120156752Search in Google Scholar
Xu G, Fan G, Sun Y, Yu L, Wu S, Niu W. Association of angiotensin-converting enzyme gene I/D polymorphism with chronic obstructive pulmonary disease: A meta-analysis. Journal of the Renin-Angiotensin-Aldosterone System 2018;13: 2435–2446.XuGFanGSunYYuLWuSNiuWAssociation of angiotensin-converting enzyme gene I/D polymorphism with chronic obstructive pulmonary disease: A meta-analysisJournal of the Renin-Angiotensin-Aldosterone System2018132435244610.1177/1470320318770546595431929716409Search in Google Scholar
Kanazawa H, Otsuka T, Hirata K, Yoshikawa J. Association between the angiotensin converting enzyme gene polymorphisms and tissue oxygenation during exercise in patients with COPD. Chest. 2002;121: 697–701.KanazawaHOtsukaTHirataKYoshikawaJAssociation between the angiotensin converting enzyme gene polymorphisms and tissue oxygenation during exercise in patients with COPDChest200212169770110.1378/chest.121.3.69711888948Search in Google Scholar
Cox R, Bouzekri N, Martin S. Angiotensin-1-converting enzyme (ACE) plasma concentration is influenced by multiple ACE-linked quantitative trait nucleotides. Human Molecular Genetics. 2002;11: 2969–2977.CoxRBouzekriNMartinSAngiotensin-1-converting enzyme (ACE) plasma concentration is influenced by multiple ACE-linked quantitative trait nucleotidesHuman Molecular Genetics2002112969297710.1093/hmg/11.23.296912393808Search in Google Scholar
Ahsan A, Ram R, Baig MA. ACE I allele and eNOS G allele crosstalk may have a role in chronic obstructive pulmonary disease. Clinical Biochemistry. 2004;37: 1037–1040.AhsanARamRBaigMAACE I allele and eNOS G allele crosstalk may have a role in chronic obstructive pulmonary diseaseClinical Biochemistry2004371037104010.1016/j.clinbiochem.2004.05.02615498534Search in Google Scholar
Kuzubova NA, Chukhlovin AB, Morozova EB, Totolian AA, Titova ON. Common intronic D variant of ACE gene is associated with endothelial dysfunction in COPD. Respiratory Medicine. 2013;107: 1217–1221.KuzubovaNAChukhlovinABMorozovaEBTotolianAATitovaONCommon intronic D variant of ACE gene is associated with endothelial dysfunction in COPDRespiratory Medicine20131071217122110.1016/j.rmed.2012.12.02523702088Search in Google Scholar
